Going digital in its 2nd year, the Blood-Brain Barrier (BBB) Summit is the industry’s definitive BBB conference focused on sharing the latest scientific advances, data and key lessons learned for transporting more drugs across the BBB. With a heavy focus on biologics, for neurodegenerative diseases, this summit will discuss topics such as quantitative methodologies for measuring amount and […]

Taking place on 3 – 4 September 2020 in Berlin, ProcureCon Pharma is your only opportunity to benchmark with the leaders of pharma procurement. Join 120+ senior procurement professionals from Merck, Astra Zeneca, Roche, Sanofi, Lonza and other world leading Pharma businesses over 2 days and 40 interactive sessions that will help you make better […]

After an exceptionally successful inaugural launch last year, the 2nd Annual Glioblastoma Drug Development Summit returns this year in an exclusive virtual format. GBM Drug Development is the only devoted meeting for large pharma, biotech and pioneering academics which guarantees to unite all stakeholders under a mutual and ambitious objective of accelerating the practical discovery, translation, and clinical development of […]

SMi is proud to announce the inaugural Prefilled Syringes San Francisco event taking place in September 2020. The global pre-filled syringes market was valued at $4.9 billion in 2018 and with the rapid growth of the industry, is expected to exceed $9.7 billion by 2025. With that in mind, this event will bring together specialists […]

Future Pharma September 14 – 15, 2020 Boston Marriott Long Wharf, Boston, MA www.pharmaforce.wbresearch.com Future Pharma is a two-day event that brings together heads of brands and franchises, marketing, sales and digital executives from leading pharmaceutical companies in an interactive and energizing setting. It is the only conference designed to help commercial leadership evaluate their […]

Via the latest data driven case studies from academic and industry pioneers, the 2nd RAS Targeted Drug Development Summit (running digitally this year!) will shine a spotlight on optimizing the selectivity and tolerability of your anti-RAS therapies, exploring novel combination strategies and overcome translational pharmacology challenges to set the stage for the 2nd generation of mutation-targeted RAS modulating […]

The #1 event for oligonucleotide, peptide, CRISPR and mRNA therapeutic leaders. Join us for top-notch networking, high-level industry expert speakers, innovative company presentations, interactive scientific poster presentations, and diverse attendee companies and investors -- in a multi-day digital format that you can access from anywhere in the world.

Transforming to a digital platform for the eleventh year, the World Bispecific Summit will continue to deliver a greater scope and penetration of innovative technical content than any other meeting. This year’s re-imagined agenda will cover unique discovery, translational and manufacturing challenges faced in the bispecific field. Whatever your role and interest in the field, […]

Priming the immune system against solid tumors by leveraging immune checkpoint blockade has proven to be an effective tool in multiple malignancies. Following the success of PD1/PDL1 checkpoint inhibitors a new wave of ICI now enters the clinic, amongst which TIGIT has shown exciting preliminary results and sparked great excitement in this nascent field. With 27 […]

With deals in the protein degradation market reaching nearly $2 billion and unique degradation ideas coming into play such as LYTACs and ENDTACs, eyes are focused on how much further protein degradation-based therapeutics will continue to grow within the pharmaceutical industry. Following huge success in May 2019, the 2nd European Protein Degradation Congress, returns on 28th […]

The inaugural Gene Therapy for Inherited Metabolic Disorders Summit will put the spotlight on the understanding of topics from the physiopathology of disease through to the nuances of dosing and delivery methods and designing a trial with endpoints and outcome measures that are meaningful both clinically and to patients. Join 60+ industry leaders across the […]

Accelerating the Development of Gamma Delta T Therapies in Oncology Join us on Wednesday, September 30, to discuss the precise mechanisms of γδT cells, examine donor selection for allogeneic therapies, and deliberate the targeting of solid tumours. As we virtually gather world-leading researchers at the Gamma Delta T Therapies Summit, learn how the industry is […]

The Digital 5th PREDiCT: 3D Oncology & Tissue Models Summit will return this September, with defined tracks and a fresh speaker line-up, bringing together preclinical scientists to discuss adoption and commercialization of 3D models as an integral part of drug development study. This event is completely free for Drug Developers, Researchers and Academics. To register your complimentary […]